The NHS missed my diagnosis for years – so I spent £5,000 on treatment in Belgium
Yasmin Gharbi, a 32-year-old civil servant, struggled for years to receive proper diagnosis and treatment for what was later identified as polyendocrine metabolic ovarian syndrome (PMOS). After eight months of appointments and referrals, she was diagnosed with the condition, which includes symptoms such as irregular periods, insulin resistance, and difficulty conceiving. Despite being aware of her condition, she faced significant delays in accessing care through the NHS, with a waitlist of a year for specialist appointments. Frustrated by the lack of support and inadequate explanations from healthcare professionals, Gharbi opted to seek treatment in Belgium, where she received more comprehensive care and detailed explanations about her condition. Over five years, she incurred approximately £5,000 in costs for consultations and surgery. The National Institute for Health and Care Excellence (NICE) recently released draft guidelines advocating for faster diagnosis and annual monitoring for women with PMOS, highlighting the underdiagnosis and poor management of the condition in the UK. Gharbi’s experience reflects broader issues within the NHS, particularly regarding patient care, wait
Ženske s poliendokrinim metaboličnim sindromom jajčnikov (PMOS) bi morale opravljati letne preglede NHS, da bi odkrile in obvladovale široko paleto zdravstvenih zapletov, povezanih s tem stanjem, v skladu z novimi smernicami, ki jih je izdal Nacionalni inštitut za zdravje in oskrbo (NICE).
V osnutku smernic NICE je opisan celovit pristop k diagnosticiranju in zdravljenju PMOS-a, pri čemer je poudarjen pomen zgodnjega odkrivanja in rednega spremljanja. Ta pogoj, ki je vodilni vzrok za žensko neplodnost, ima simptome, kot so nepravilni ali odsotni obdobji, prekomerni lasje na obrazu in telesu, povečanje telesne teže, izpadanje las, mastna koža in akne.
Kljub temu, da v Veliki Britaniji prizadene do štiri milijone žensk, je PMOS še vedno poddiagnosticiran in neustrezno obravnavan v okviru NHS. Mnogi posamezniki poročajo o zamudah pri diagnozi in omejenem dostopu do ustrezne oskrbe. Na primer, Yasmin Gharbi, 32-letna državna uslužbenka, se je leta borila za pravilno diagnozo in učinkovito zdravljenje za PMOS. Njeni začetni simptomi - neobjasnjena bolečina in nepravilno menstruacijo - so pripeljali do niza napačnih diagnoz in neučinkovitih posegov.
Vendar pa je pomanjkanje ustreznih informacij in podpore s strani NHS služb prisililo Gharbi, da je iskala zdravljenje v tujini v Belgiji, kjer je imela po ocenah 5.000 funtov stroškov.
Podobno se je Emily Mee, 29-letna ženska, kljub obstojnim simptomom soočila z večkratnimi odpustki strokovnjakov NHS. Njena pot do diagnoze se je začela z leti nepravilnih menstruacij in nedokončanih testov. Dokler ni predstavila svojih simptomov na oddelku za nujne primere prek ChatGPT - orodja, ki ga je uporabljala za raziskovanje možnih vzrokov - ni prejela začasnega predloga o raztrganem jajčniku, povezanem z PMOS.
Cilj NICE-ovih smernic je odpraviti te vrzeli s spodbujanjem standardiziranih diagnostičnih protokolov in spodbujanjem izvajalcev zdravstvenega varstva, da upoštevajo PMOS pri ženskah vseh starosti, vključno s tistimi po menopavzi.
Osnutek smernic je zdaj odprt za javne in strokovne povratne informacije do 11. avgusta 2026, končna različica pa naj bi bila objavljena decembra 2026. Če se bodo nova priporočila izvajala, bi lahko vodila k boljšim rezultatom bolnikov, večji ozaveščenosti o PMOS in doslednejši oskrbi po celotnem NHS. Ker zagovorniki, kot je Gharbi, še naprej poudarjajo pomanjkljivosti sedanjega sistema, je upanje, da bodo te smernice zaznamovale prelomnico pri razumevanju in upravljanju PMOS v okviru zdravstvenega varstva v Združenem kraljestvu.
Pojdite k primarnim virom (4)
Uradni viri, na katerih temelji poročanje. Preberite jih neposredno in se izognite uokvirjanju.
The article discusses new guidance from the National Institute for Health and Care Excellence (NICE) regarding the management of Polycystic Ovary Syndrome (PMOS), formerly known as polycystic ovary syndrome. The guidance recommends annual NHS checks for women with PMOS to detect related health issues early. It highlights that PMOS affects approximately one in eight women and is a leading cause of female infertility, with symptoms including irregular periods, excessive hair growth, and weight gain. Despite its prevalence, PMOS remains underdiagnosed and inconsistently managed. The guidance emphasizes the importance of diagnosing PMOS in post-menopausal women and acknowledges racial disparities in its occurrence. It also notes the lack of a cure but mentions available treatments like hormone therapy and fertility drugs. Laser and light therapies for hair reduction are discouraged due to cost concerns. The draft guidance is open for public comment until August 2026, with final publication expected in December 2026.
Ocena pristranskosti (Sredina): The article presents factual information about medical guidelines and does not take a partisan stance. It reports on the recommendations of NICE, a government-funded health authority, without expressing ideological preferences. While the topic relates to public health policy, the framing remains non
Zakaj te ocene (Dejstva 95 · Objektivnost 88): Factuality is high as the article accurately reflects the content of the NICE draft guidance, including the renaming of PCOS to PMOS in May 2026 and the recommendations for annual checks. Objectivity is slightly lower due to some emotionally charged language like 'under-diagnosed' and 'inconsistentl
Yasmin Gharbi, a 32-year-old civil servant, struggled for years to receive proper diagnosis and treatment for what was later identified as polyendocrine metabolic ovarian syndrome (PMOS). After eight months of appointments and referrals, she was diagnosed with the condition, which includes symptoms such as irregular periods, insulin resistance, and difficulty conceiving. Despite being aware of her condition, she faced significant delays in accessing care through the NHS, with a waitlist of a year for specialist appointments. Frustrated by the lack of support and inadequate explanations from healthcare professionals, Gharbi opted to seek treatment in Belgium, where she received more comprehensive care and detailed explanations about her condition. Over five years, she incurred approximately £5,000 in costs for consultations and surgery. The National Institute for Health and Care Excellence (NICE) recently released draft guidelines advocating for faster diagnosis and annual monitoring for women with PMOS, highlighting the underdiagnosis and poor management of the condition in the UK. Gharbi’s experience reflects broader issues within the NHS, particularly regarding patient care, wait
Ocena pristranskosti (Levo): The article frames the shortcomings of the NHS as systemic failures, emphasizing the lack of adequate care, delayed diagnoses, and insufficient support for patients with PMOS. The narrative highlights the contrast between the NHS and private care in Belgium, implying a failure of the UK healthcare体系
★
Ohranimo novice poštene.
ObjectiveNews financirajo bralci in je brez oglasov – pristranskost vam pokažemo, ne skrijemo. Podprite neodvisno novinarstvo za 5 €/mesec.
United Kingdom
